Stockreport

Akari Therapeutics reports Q4 results [Seeking Alpha]

Akari Therapeutics Plc - American Depositary Shares  (AKTX) 
US:NASDAQ Investor Relations: investor.akaritx.com/investor-relations
PDF Akari Therapeutics reports Q4 resultsAkari Therapeutics (NASDAQ:AKTX): Q4 EPS of -$0.01Press ReleaseClick to subscribe to real-time analytics on AKTXNow read:Alexion Ups [Read more]